We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Enzon Opens a Phase 2 Study of PEG-SN38 for Metastatic Breast Cancer

News   Jan 07, 2010

 
Enzon Opens a Phase 2 Study of PEG-SN38 for Metastatic Breast Cancer
 
 
 

RELATED ARTICLES

It's Time to Keep Check on the Microbiome

News

Scientists have developed a novel technique based on an oscillating gene circuit that they hope will help to shed light on the human microbiome.

READ MORE

Powerful Technique Tracks Down Genetic Disease

News

A team led by a scientist at Scripps Research has invented a new genomics technique for tracking down the causes of rare genetic diseases. The new method compares activity levels of maternal and paternal alleles across the genome and detects when the activity of an allele lies far enough outside the normal range to be a plausible cause of disease.

READ MORE

Drug Prevents Liver Scarring in People With HIV

News

A new study reports that the injectable hormone tesamorelin reduces liver fat and prevents liver fibrosis (scarring) in people living with HIV.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE